BIOMARIN PHARMACEUTICAL INC Derivative Liability, Current
BIOMARIN PHARMACEUTICAL INC (BMRN) had Derivative Liability, Current of $33.52 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Derivative Liability, Current $33.52M.
- 2026-03-31: Derivative Liability, Current $31.68M.
- 2025-12-31: Derivative Liability, Current $31.01M.
- 2025-09-30: Derivative Liability, Current $43.74M.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $33.52M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $31.68M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $31.01M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $43.74M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $55.31M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $15.52M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $13.06M 10-K · filed 2026-02-26 | $7.57M 10-K · filed 2025-02-24 |
| 2024-09-30 | $14.30M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $7.68M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $13.68M 10-Q · filed 2024-04-26 | |
| 2023-12-31 | $8.78M 10-K · filed 2025-02-24 | $33.85M 10-K · filed 2024-02-26 |
| 2023-09-30 | $10.58M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $19.57M 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $15.96M 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $12.60M 10-K · filed 2024-02-26 | |
| 2022-09-30 | $13.07M 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $10.22M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $12.72M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $6.26M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $5.32M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $11.03M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $8.64M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $17.80M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $7.77M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $7.43M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $7.67M 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $10.45M 10-K · filed 2021-02-26 | |
| 2019-09-30 | $8.73M 10-Q/A · filed 2019-11-04 | |
| 2019-06-30 | $6.42M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $6.90M 10-Q · filed 2019-04-29 | |
| 2018-12-31 | $4.18M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $6.44M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $7.17M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $20.62M 10-Q · filed 2018-04-27 | |
| 2017-12-31 | $14.46M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $14.43M 10-Q · filed 2017-10-31 | |
| 2016-12-31 | $5.20M 10-K · filed 2018-02-26 | |
| 2011-12-31 | $194.00K 10-K · filed 2012-02-22 | |
| 2011-09-30 | $926.00K 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $6.08M 10-Q · filed 2011-08-01 | |
| 2010-12-31 | $1.67M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |